FRASCA, ANGELISA
FRASCA, ANGELISA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Neural precursor cells rescue symptoms of Rett syndrome by activation of the Interferon γ pathway
2024 A. Frasca, F. Miramondi, E. Butti, M. Indrigo, M. BALBONTIN ARENAS, F.M. Postogna, A. Piffer, F. Bedogni, L. Pizzamiglio, C. Cambria, U. Borello, F. Antonucci, G. Martino, N. Landsberger
Mecp2 knock-out astrocytes affect synaptogenesis by Interleukin 6 dependent mechanisms
2024 E. Albizzati, M. Breccia, E.M. Florio, C. Cabasino, F.M. Postogna, R. Grassi, E. Boda, C. Battaglia, C. DE PALMA, C. De Quattro, D. Pozzi, N. Landsberger, A. Frasca
Neural precursor cells rescue symptoms of Rett syndrome by activation of the Interferon γ pathway
2024 A. Frasca, F. Miramondi, E. Butti, M. Indrigo, M. BALBONTIN ARENAS, F. M Postogna, A. Piffer, F. Bedogni, L. Pizzamiglio, C. Cambria, U. Borello, F. Antonucci, G. Martino, N. Landsberger
Neural Precursor Cells as a potential therapeutic approach for Rett Syndrome: identification of the involved molecular mechanisms
2024 M. BALBONTIN ARENAS, F.M. Postogna, E. Butti, A. Frasca, N. Landsberger
Clinical-grade intranasal NGF fuels neurological and metabolic functions of Mecp2-deficient mice
2024 D. Pozzer, M. Indrigo, M. Breccia, E. Florio, C.A. Franchino, G. De Rocco, F. Maltecca, A. Fadda, M. Rossato, A. Aramini, M. Allegretti, A. Frasca, L. De Filippis, N. Landsberger
GM1 Oligosaccharide Ameliorates Rett Syndrome Phenotypes In Vitro and In Vivo via Trk Receptor Activation
2024 M. Fazzari, G. Lunghi, E.V. Carsana, M. Valsecchi, E. Spiombi, M. Breccia, S.R. Casati, S. Pedretti, N. Mitro, L. Mauri, M.G. Ciampa, S. Sonnino, N. Landsberger, A. Frasca, E. Chiricozzi
Neural precursor/stem cell-based therapy for Rett syndrome
2023 A. Frasca, F. Miramondi, M. Balbontin, M. Indrigo, E. Butti, U. Borello, F. Bedogni, G. Martino, N. Landsberger
Neural Precursor Cells as a potential therapeutic approach for Rett Syndrome: identification of the involved molecular mechanisms
2023 M. BALBONTIN ARENAS, F. Miramondi, E. Butti, G. Martino, A. Frasca, N. Landsberger
A comprehensive longitudinal study of magnetic resonance imaging identifies novel features of the Mecp2 deficient mouse brain
2023 S. Carli, L. Chaabane, G. De Rocco, E. Albizzati, I. Sormonta, S. Calligaro, P. Bonizzi, A. Frasca, N. Landsberger
The detrimental effect of Mecp2 null astrocytes on synapses: exploring the molecular mechanisms to find novel druggable targets for Rett syndrome
2023 E. Albizzati, E.M. Florio, M. Breccia, C. Cabasino, D. Pozzi, E. Boda, C. Battaglia, C. DE PALMA, Concetta De Quattro, N. Landsberger, A. Frasca
MeCP2 deficiency in astrocytes alters synaptogenesis: new insights on Rett syndrome
2023 M. Breccia, E. Albizzati, E. Florio, C. Cabasino, D. Pozzi, E. Boda, C. Battaglia, C. De Palma, C. De Quattro, N. Landsberger, A. Frasca
New Views of the DNA Repair Protein Ataxia–Telangiectasia Mutated in Central Neurons: Contribution in Synaptic Dysfunctions of Neurodevelopmental and Neurodegenerative Diseases
2023 S. Briguglio, C. Cambria, E. Albizzati, E. Marcello, G. Provenzano, A. Frasca, F. Antonucci
PURPL and NEAT1 Long Non-Coding RNAs Are Modulated in Vascular Smooth Muscle Cell Replicative Senescence
2023 C. Rossi, M. Venturin, J. Gubala, A. Frasca, A. Corsini, C. Battaglia, S. Bellosta
Neural precursor/stem cell-based therapy for Rett syndrome
2022 A. Frasca, F. Miramondi, E. Butti, M. Indrigo, G. DE ROCCO, F. Bedogni, G. Martino, N. Landsberger
MeCP2 deficiency in astrocytes alters synaptogenesis: new insights on Rett syndrome
2022 E. Albizzati, E.M. Florio, M. Breccia, C. Cabasino, D. Pozzi, C. DE PALMA, N. Landsberger, A. Frasca
Identification of Region-Specific Cytoskeletal and Molecular Alterations in Astrocytes of Mecp2 Deficient Animals
2022 E. Albizzati, E. Florio, F. Miramondi, I. Sormonta, N. Landsberger, A. Frasca
Not Just Loss-of-Function Variations: Identification of a Hypermorphic Variant in a Patient With a CDKL5 Missense Substitution
2022 A. Frasca, E. Pavlidou, M. Bizzotto, Y. Gao, D. Balestra, M. Pinotti, H.A. Dahl, N.D. Mazarakis, N. Landsberger, M. Kinali
In vivo magnetic resonance spectroscopy in the brain of Cdkl5 null mice reveals a metabolic profile indicative of mitochondrial dysfunctions
2021 S. Carli, L. Chaabane, C. Butti, C. De Palma, P. Aimar, C. Salio, A. Vignoli, M. Giustetto, N. Landsberger, A. Frasca
Ongoing Electroencephalographic Rhythms Related to Exploratory Movements in Transgenic TASTPM Mice
2020 C. Del Percio, W. Drinkenburg, S. Lopez, M.T. Pascarelli, R. Lizio, G. Noce, R. Ferri, J.F. Bastlund, B. Laursen, D.Z. Christensen, J.T. Pedersen, G. Forloni, A. Frasca, F.M. Noe, P.F. Fabene, G. Bertini, V. Colavito, M. Bentivoglio, J. Kelley, S. Dix, F. Infarinato, A. Soricelli, F. Stocchi, J.C. Richardson, C. Babiloni
Chronic BACE-1 Inhibitor Administration in TASTPM Mice (APP KM670/671NL and PSEN1 M146V Mutation): An EEG Study
2020 S. Lopez, C. Del Percio, G. Forloni, A. Frasca, W.H. Drinkenburg, R. Lizio, G. Noce, R. Ferri, A. Soricelli, F. Stocchi, L. Vacca, R. Bordet, J.C. Richardson, C. Babiloni